FEAM Statement on Mental Health Policy Issues

Das Thema psychische Erkrankungen wurde in der EU-Politik bisher vernachlässigt. Die derzeitige Praxis in der Psychiatrie wird erschwert durch ein unzureichendes biologisches Verständnis psychischer Störungen, mangelnde Anerkennung, Stigmatisierung, ein Mangel an wirksamen Therapien und einen schlechten Zugang zur Gesundheitsversorgung. Der vorliegende Bericht stützt sich auf die Diskussion kritischer Fragen der Psychiatrie auf dem FEAM-Treffen in Prag 2009.The present report draws on discussion from a Prague meeting organised in 2009 by FEAM (Federation of European Academies of Medicine) to review some of the critical issues in contemporary psychiatry and is intended to provide advice to decision-makers at the EU and national levels in developing a more coherent policy for mental health. We cover policy priorities relating to research and public health for major contributors to the disease burden, including depression, bipolar disorder, schizophrenia, and their co-morbidities. We also address cross-cutting issues for mental health policy, including stigma, suicide, addiction, workplace stress and the challenges of adolescence and ageing

Opportunities and Challenges for Reforming the EU Clinical Trials Directive: an Academic Perspective : Statement

The introduction of the Clinical Trials Directive (CTD), intended to harmonise authorisation of EU Clinical Trials on medicinal products and to improve the collection of reliable data, has been controversial. While increased support for multi-national collaboration is very important, the CTD has dramatically increased the administrative burden and costs for academia and has deterred academic clinical research

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Until recently, human genetic testing was mainly confined to specialist medical genetic services, traditionally focusing on the relatively rare inherited disorders. However, the rapid pace of advance in DNA analysis has led to increasing interest in the development of genetic tests for determining susceptibility to the more common, complex disorders. Such tests are increasingly being offered by companies through the internet. These consumer genetic services raise scientific, regulatory and ethical questions. Various concerns have been expressed about the quality and validity of the direct-to-consumer genetic testing offered, the clinical usefulness of the information supplied and the implications for the consumer, their family and the public health services. These issues affect all of us and are of sufficient importance and relevance to warrant attention by all the national academies in the European Union (EU). Our Report represents the first joint project between the academies of science in EASAC (the European Academies Science Advisory Council) and of medicine in FEAM (the Federation of European Academies of Medicine); we decided to collaborate on this occasion and in this way to draw upon the widest possible expertise in the scientific disciplines and experience in the Member States

International Sharing of Personal Health Data for Research: the ALLEA, EASAC and FEAM joint initiative on resolving the barriers of transferring public sector data outside the EU/EEA

Personal health data provide a vital resource for research to save and improve lives, reduce health inequalities and benefit society. Research data should be regarded as a global public good. Sharing of data is an essential part of public sector medical research for improved health care and disease prevention, for example to ensure sufficiently large sample sizes, identify complex pathways, and compare the determinants and outcomes of disease in different settings, thereby making the most of the contribution by patients and volunteers to research. It is important for EU citizens that their data are shared for health research, to ascertain whether research results from elsewhere are relevant to their particular genetic makeup and risk factors. At the same time, it is essential to provide appropriate protections for personal data privacy. The General Data Protection Regulation (GDPR) addresses the protection of personal data in the European Union (EU) and European Economic Area (EEA) and the international transfer of data to areas outside the region. It has become apparent that the implementation of the GDPR has introduced impediments to this international transfer of data to outside the EU/EEA, creating problems for academic researchers, healthcare professionals and others in the public sector. These problems affect patients and all citizens who are the ultimate beneficiaries of public sector health research

Minas sem lixões - Parte 1

O vídeo apresenta as formas de disposição final de resíduos sólidos, alertando sobre os riscos ambientais e sociais de se dispor o lixo na forma de lixões irregulares. Neste segmento do vídeo são abordadas as degradações ambientais ocorrentes no Brasil, como a devastação das coberturas vegetais originais e a poluição ocasionada pela disposição de resíduos sólidos. Trata ainda sobre o conceito de desenvolvimento sustentável, mostrando maneiras de como a sociedade pode contribuir para alcançá-lo, começando pelo gerenciamento do próprio lixoEnsino Fundamental Final::Meio Ambient

Challenges and potential in regenerative medicine: a joint report from EASAC and FEAM

Regenerative medicine comprises novel interdisciplinary approaches, including several based on cell and gene therapies, aimed at tissue regeneration and repair. All regenerative medicine strategies depend upon harnessing, stimulating, guiding or replacing endogenous developmental or repair processes. Regenerative medicine offers significant promise for treating intractable diseases but, so far, has proved itself in only a few specific clinical indications, for example for haematopoietic and skin disorders. Stem-cell-based medicine is now established and will undoubtedly advance towards treating a progressively larger spectrum of diseases, so it is essential to address some critical scientific issues for evidence-based implementation and regulation. The consequences of not doing this would be to waste investment, researcher activity and aspirations to cure, as well as to undermine patient protection. This report, from a project conducted by EASAC (European Academies’ Science Advisory Council) and FEAM (Federation of European Academies of Medicine), explores opportunities and challenges in this rapidly advancing field, discusses what principles should be offered for guidance in policy development and what the strategic priorities are in the European Union (EU) for products in the category of advanced therapy medicinal products, which includes those used for regenerative medicine

Minas sem lixões - Parte 1

Ensino Fundamental Final::Meio AmbienteO vídeo apresenta as formas de disposição final de resíduos sólidos, alertando sobre os riscos ambientais e sociais de se dispor o lixo na forma de lixões irregulares. Neste segmento do vídeo são abordadas as degradações ambientais ocorrentes no Brasil, como a devastação das coberturas vegetais originais e a poluição ocasionada pela disposição de resíduos sólidos. Trata ainda sobre o conceito de desenvolvimento sustentável, mostrando maneiras de como a sociedade pode contribuir para alcançá-lo, começando pelo gerenciamento do próprio lix

Minas sem lixões - Parte 2

O vídeo apresenta as formas de disposição final de resíduos sólidos, alertando sobre os riscos ambientais e sociais de se dispor o lixo na forma de lixões irregulares. Neste segmento do vídeo são apresentadas as medidas técnicas que devem ser tomadas pelos municípios que ainda possuem lixões, de modo a se adaptar à nova legislação que visa erradicar tal forma de disposição de resíduosEnsino Fundamental Final::Meio Ambient